Five-Pillar Stock Analysis

United Therapeutics Corporation (UTHR)

Get a clear, structured breakdown of United Therapeutics Corporation (UTHR) across the five pillars that matter most: Valuation, Profitability, Financial Health, Returns, and Growth — all in one place.

View UTHR Full Analysis →

Five-Pillar Analysis for UTHR

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes United Therapeutics Corporation a strong or weak investment candidate.

▲ Valuation

Is UTHR priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and UTHR's own history. Our valuation engine flags whether United Therapeutics Corporation is trading rich, fair, or cheap.

▲ Profitability

How efficient is United Therapeutics Corporation?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can UTHR survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen United Therapeutics Corporation's balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's UTHR earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare United Therapeutics Corporation's capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is United Therapeutics Corporation expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete UTHR breakdown

Sign up free to unlock United Therapeutics Corporation's full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about UTHR

Quick answers to the most common questions about United Therapeutics Corporation.

What does United Therapeutics Corporation (UTHR) do?
United Therapeutics Corporation is a publicly traded company under the ticker symbol UTHR. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.
How do I analyze UTHR stock?
The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including UTHR. Each pillar uses standardized metrics that let you compare United Therapeutics Corporation to its peers and to its own history.
Is UTHR a good stock to buy?
Whether United Therapeutics Corporation fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.
Where can I see UTHR's financial data?
Sign up free at TopTier Strategy to access United Therapeutics Corporation's complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

See UTHR's full five-pillar analysis

Free account. 5 stock searches per day. No credit card required.

Sign Up Free